-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Transcode Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q4 2024.
- Transcode Therapeutics, Inc. Operating Lease, Payments for the quarter ending December 31, 2024 was $153K, a 71.8% increase year-over-year.
- Transcode Therapeutics, Inc. Operating Lease, Payments for the twelve months ending December 31, 2024 was $412K, a 28.4% decline year-over-year.
- Transcode Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $412K, a 28.4% decline from 2023.
- Transcode Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $575K, a 74.5% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)